Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: Involvement of a nitric oxide-dependent pathway

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 5770-5780

  Gurlo, Tatyana ^a   Kawamura, Kenneth ^a   Von Grafenstein, Hermann ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOSTIMULATION; INFLAMMATORY INFILTRATE; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CLONE CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; ISLETS OF LANGERHANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYSINE; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION; SPLEEN;

EID: 0033485751     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Andre, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93:2260.
2. Atkinson, M. A., and N. K. Maclaren. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331:1428.
3. Tarui, S., Y. Tochino, and K. Nonaka. 1986. Insulitis and Type I Diabetes -Lessons from the NOD Mouse. Academic Press, Orlando, FL.
4. Kolb, H., V. Burkart, B. Appels, H. Hanenberg, G. Kantwerl-Funke, U. Kiesel, J. Funda, U. Schraermeyer, and V. Kolb-Bachofen. 1990. Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmun. 3:117.
5. Hutchings, P., H. Rosen, L. O'Reilly, E. Simpson, S. Gordon, and A. Cooke. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptors on macrophages. Nature 348:639.
6. + T cells. J. Exp. Med. 166:823.
7. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140:52.
8. Serreze, D. V., H. D. Chapman, D. S Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig μ null mice. J. Exp. Med. 184:2049.
9. Noorchashm, H., N. Noorchashm, J. Kern, S. Y. Rostami, C. F. Barker, and A. Naji. 1997. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46:941.
10. Akashi, T., S. Nagafuchi, K. Anzai, S. Kondo, D. Kitamura, S. Wakana, J. Ono, M. Kikuchi, Y. Niho, and T. Watanabe. 1997. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9:1159.
11. + T-cells from diabetic versus prediabetic NOD.NON-Thy-la donors. Diabetes 42:44.
12. Wong, F. S., I. Visintin, L. Wen, R. A. Flavell, and C. A. Janeway, Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67.
13. Green, E. A., E. E. Eynon, and R. A. Flavell. 1998. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9:733.
14. Lo, D., C. R. Reilly, B. Scott, R. Liblau, H. O. McDevitt, and L. C. Burkly. 1993. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur. J. Immunol. 23:1693.
15. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
16. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
17. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.
18. Kundig, T. M., M. F. Bachmann, C. DiPaolo, J. J. Simard, M. Battegay, H. Lother, A. Gessner, K. Kuhlcke, P. S. Ohashi, H. Hengartner, et al. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343.
19. Zinkernagel, R. M., S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner. 1997. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156: 199.
20. Sarvetnick, N., J. Shizuru, D. Liggitt, L. Martin, B. McIntyre, A. Gregory, T. Parslow, and T. Stewart. 1990. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346:844.
21. Lee, M. S., M. von Herrath, H. Reiser, M. B. Oldstone, and N. Sarvetnick. 1995. Sensitization to self (virus) antigen by in situ expression of murine interferon-γ. J. Clin. Invest. 95:486.
22. McDaniel, M. L., G. Kwon, J. R. Hill, C. A. Marshall, and J. A. Corbett. 1996. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:24.
23. Stassi, G., R. D. Maria, G. Trucco, W. Rudert, R. Testi, A. Galluzzo, C. Giordano, and M. Trucco. 1997. Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193.
24. Karasuyama, H., and F. Melchers. 1988. Establichment of mouse cell lines which constitutively produce large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
25. Agostino, M., S. J. Prowse, and K. J. Lafferty. 1982. Resistance of established islet allografts to rejection by antibody and complement. Aust. J. Exp. Biol. Med. Sci. 60:219.
26. Hamaguchi, K., H. R. Gaskins, and E. H. Leiter. 1991. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes 40:842.
27. Eizirik, D. L., M. Flodstrom, A. E. Karlsen, and N. Welsh. 1996. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic β cells. Diabetologia 39:875.
28. Heitmeier, M. R., A. L. Scarim, and J. A. Corbett. 1997. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin-1 J. Biol. Chem. 272:13697.
29. Arnush, M., A. L. Scarim, M. R. Heitmeier, C. B. Kelly, and J. A. Corbett. 1998. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J. Immunol. 160:2684.
30. G-monomethyl-arginine in vitro and in vivo. Eur. J. Pharmacol. 294:703.
31. Jun, H. S., C. S. Yoon, L. Zbytnuik, N. van Rooijen, and J. W. Yoon. 1999. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 189:347.
32. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480.
33. + T cells of non-obese diabetic mice. J. Immunol. 151: 1723.
34. Campbell, I. L., A. Iscaro, and L. C. Harrison. 1988. IFN-γ and tumor necrosis factor-α: cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325.
35. Hultgren, B., X. Huang, N. Dybdal, and T. A. Stewart. 1996. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812.
36. Wang, B., I. Andre, A. Gonzalez, J. D. Katz, M. Aguet, C. Benoist, and D. Mathis. 1997. Interferon-γ impacts at multiple points during the progression of autoimmune diabetes. Proc. Nat. Acad. Sci. USA 94:13844.
37. Pakala, S. V., M. Chivetta, C. B. Kelly, and J. D. Katz. 1999. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J. Exp. Med. 189:1053.
38. Pankewycz, O. G., J. X. Guan, and J. F. Benedict. 1995. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr. Rev. 16:164.
39. Rabinovitch A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diab. Metabol. Rev. 14:129.
40. Rothe, H., N. A. Jenkins, N. G. Copeland, and H. Kolb. 1997. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin. Invest. 99:469.
41. Rabinovitch, A., W. L. Suarez Pinzon, O. Sorensen, R. C. Bleackley, and R, F. Power. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:4874.
42. + T cells are required for IFN-γ gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats. J. Autoimmun. 12:109.